Table 4. Lines of treatment.

	Division
Total number of deaths identified from HIS	GI tract	Urology	Lung	Breast	Gynae	Clinical pharmacology	Skin and melonoma	Sarcoma	Head and neck	Paediatrics	Lymphoma	Myeloma	Leukaemia	Neuro-Oncology	Total
Total no. of deaths	20	5	24	32	17	2	8	14	6	4	5	6	15	3	161
Patients on 1st line therapy	11	2	11	3	3	0	4	4	0	2	0	1	2	1	44 (27%)
Patient on 2nd line therapy	1	0	6	7	3	0	3	8	6	1	1	0	2	1	39 (24%)
Patients on 3rd line or subsequent therapy	7	3	6	21	10	2	0	2	0	1	4	5	10	1	72 (45%)
Line of therapy not known/not applicable	1	0	1	1	1	0	1	0	0	0	0	0	1	0	6 (4%)
Total no. of deaths related to neo-adjuvant/adjuvant treatments	2	0	0	1	0	0	0	0	1	1 (1)	0	2	4	0	12